Lexicon Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
LXRX Lexicon Pharmaceuticals Inc
ASLE AerSale Corp
CPRT Copart Inc
AOGO Arogo Capital Acquisition Corp
CTPCY CITIC Ltd
LIFW MSP Recovery Inc
ASNS Actelis Networks Inc
AHI Advanced Health Intelligence Ltd
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Its LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of SGLT2 in the kidney.

Closing Price
$1.03
Day's Change
-0.01 (-0.96%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.04
Day's Low
0.9596
Volume
(Heavy Day)
Volume:
3,806,613

10-day average volume:
1,992,431
3,806,613
  • Prev Close
    1.04
  • Today's Open
    1.03
  • Day's Range
    0.9596-1.04
  • Avg Vol (10-day)
    2.0M
  • Last (time)
    3:59p ET 10/04/23
  • Last (size)
    900
  • 52-Wk Range
    0.9596 - 3.79
    LowHigh
  • (05/05/23 - 10/04/23)
    7.34%
  • 75.3%
  • Market Cap
    252.3M
  • Shares Outstanding
    244.9M
  • -0.68
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 80.58
  • (% of float 09/15/23)
    7.80

Latest News

September 28, 2023
9:00 am ET
Globe Newswire
September 26, 2023
9:00 am ET
Globe Newswire
September 07, 2023
4:30 pm ET
Globe Newswire
9:01 am ET
Globe Newswire
August 21, 2023
9:00 am ET
Globe Newswire
August 08, 2023
9:00 am ET
Globe Newswire
August 03, 2023
4:15 pm ET
Zacks
4:01 pm ET
Globe Newswire
July 28, 2023
4:01 pm ET
Globe Newswire
8:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.